Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder.

[1]  S. Akhondzadeh.  Depression and Inflammation: Is There any Role for Biomarkers? , 2019, Avicenna journal of medical biotechnology.

[2]  Z. Gan,et al.  The association between low-grade inflammation and the clinical features of bipolar disorder in Han Chinese population , 2019, Psychoneuroendocrinology.

[3]  A. Teixeira,et al.  Revisiting inflammation in bipolar disorder , 2019, Pharmacology Biochemistry and Behavior.

[4]  P. Gałecki,et al.  Interleukin 17 and Treg – a common pathomechanism and a new target of therapy in rheumatic diseases and depression , 2018, Reumatologia.

[5]  D. Fuchs,et al.  Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder , 2018, Front. Psychiatry.

[6]  Mahmi Fujimori,et al.  Relationship between Proinflammatory Cytokines/Chemokines and Adipokines in Serum of Young Adults with Obesity. , 2018, Endocrine, metabolic & immune disorders drug targets.

[7]  W. Dębowska,et al.  Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  R. McIntyre,et al.  Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications , 2017, Brain sciences.

[9]  J. Quevedo,et al.  A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. , 2017, Journal of psychiatric research.

[10]  S. Djurovic,et al.  Persistent increase in TNF and IL‐1 markers in severe mental disorders suggests trait‐related inflammation: a one year follow‐up study , 2017, Acta psychiatrica Scandinavica.

[11]  R. Tabarés-Seisdedos,et al.  Clinical staging and serum cytokines in bipolar patients during euthymia , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  F. Kapczinski,et al.  Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder , 2017, Journal of Neuroimmunology.

[13]  M. Leboyer,et al.  Interleukin‐1 β‐targeted treatment strategies in inflammatory depression: toward personalized care , 2016, Acta psychiatrica Scandinavica.

[14]  Ni Fan,et al.  Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients , 2016, Psychiatry Research.

[15]  M. Vinberg,et al.  Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study. , 2016, Journal of affective disorders.

[16]  A. Larsson,et al.  The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid. , 2015, Cytokine.

[17]  E. Coccaro,et al.  Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder , 2015, Psychiatry Research.

[18]  W. Nolen,et al.  Inflammatory monocyte gene expression: trait or state marker in bipolar disorder? , 2015, International Journal of Bipolar Disorders.

[19]  R. McIntyre,et al.  Are medical comorbid conditions of bipolar disorder due to immune dysfunction? , 2015, Acta psychiatrica Scandinavica.

[20]  V. Mondelli,et al.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? , 2015, Psychopharmacology.

[21]  Cheng-Ta Li,et al.  Comparison of pro‐inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls , 2015, Bipolar disorders.

[22]  M. Maes,et al.  Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis , 2015, The international journal of neuropsychopharmacology.

[23]  R. Machado-Vieira,et al.  Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression , 2014, Neural plasticity.

[24]  A. Azab,et al.  Effects of lithium on inflammation. , 2014, ACS chemical neuroscience.

[25]  R. McIntyre,et al.  The theory of bipolar disorder as an illness of accelerated aging: Implications for clinical care and research , 2014, Neuroscience & Biobehavioral Reviews.

[26]  Huibert Burger,et al.  Relationship between clinical features and inflammation‐related monocyte gene expression in bipolar disorder – towards a better understanding of psychoimmunological interactions , 2014, Bipolar disorders.

[27]  M. Vinberg,et al.  Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. , 2013, Journal of psychiatric research.

[28]  E. Brietzke,et al.  Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies , 2013, Biological Psychiatry.

[29]  M. Vinberg,et al.  Cytokines in bipolar disorder: a systematic review and meta-analysis. , 2013, Journal of affective disorders.

[30]  Raffael Massuda,et al.  Pharmacological Treatment of Bipolar Depression: Qualitative Systematic Review of Double-Blind Randomized Clinical Trials , 2012, Psychiatric Quarterly.

[31]  M. Bloch,et al.  The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis , 2011, Neuropsychopharmacology.

[32]  J. Scheller,et al.  The pro- and anti-inflammatory properties of the cytokine interleukin-6. , 2011, Biochimica et biophysica acta.

[33]  Flávio Kapczinski,et al.  Peripheral biomarkers and illness activity in bipolar disorder. , 2011, Journal of psychiatric research.

[34]  V. Boussiotis,et al.  IL-1β–Mediated Signals Preferentially Drive Conversion of Regulatory T Cells but Not Conventional T Cells into IL-17–Producing Cells , 2010, The Journal of Immunology.

[35]  R. Post,et al.  A systemic toxicity index developed to assess peripheral changes in mood episodes , 2010, Molecular Psychiatry.

[36]  M. Berk,et al.  The potential use of biomarkers as an adjunctive tool for staging bipolar disorder , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[37]  E. Brietzke,et al.  Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder , 2009, Brain, Behavior, and Immunity.

[38]  E. Brietzke,et al.  Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. , 2009, Journal of affective disorders.

[39]  S. Wisniewski,et al.  The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. , 2009, Journal of affective disorders.

[40]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[41]  B. Winblad,et al.  Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL‐1ra in the mouse , 2008, The European journal of neuroscience.

[42]  T. Suppes,et al.  Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. , 2007, Bipolar disorders.

[43]  F. Goodwin,et al.  Manic-Depressive Illness. Bipolar Disorders and Recurrent Depression. Oxford (Oxford University Press) 2007. , 2007 .

[44]  Daisy R. Lee,et al.  Effect of storage temperatures on the stability of cytokines in cervical mucous. , 2007, Cytokine.

[45]  L. C. Bidwell,et al.  Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes. , 2006, Current psychiatry reviews.

[46]  C. Gabay,et al.  Interleukin-6 and chronic inflammation , 2006, Arthritis research & therapy.

[47]  L. Judd,et al.  Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. , 2005, Archives of general psychiatry.

[48]  C. Nemeroff,et al.  Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions , 2002, Neuropsychopharmacology.

[49]  R. Dantzer,et al.  Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  A. Rush,et al.  The Inventory of Depressive Symptomatology (IDS): psychometric properties , 1996, Psychological Medicine.

[51]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[52]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[53]  E. Tüzün,et al.  [Inflammation and Neurodegeneration in Patients with Early-Stageand Chronic Bipolar Disorder]. , 2019, Turk psikiyatri dergisi = Turkish journal of psychiatry.

[54]  M. Bauer,et al.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls , 2019, Journal of psychiatry & neuroscience : JPN.

[55]  M. Berk,et al.  eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors , 2010 .

[56]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[57]  R. Dantzer,et al.  Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. , 2005, The Journal of clinical psychiatry.

[58]  Robert L. Spitzer,et al.  Global Assessment of Functioning (GAF) Scale , 1996 .

[59]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[60]  Emil Kraepelin,et al.  Manic-depressive insanity and paranoia , 1976 .